Archive

Neovasc Reports Results for the First Quarter of 2015

-- Raised aggregate gross proceeds of approximately US$74,883,850 ---- The New England Journal of Medicine publishes positive results from clinical study of Reducer  ---- Company launches Reducer in select European countries -- NASDAQ: NVCNTSX: NVC VANCOUVER, May 12, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company")...

Read More

Neovasc to Present at Deutsche Bank Health Care Conference

NASDAQ: NVCNTSX: NVC VANCOUVER, May 4, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that CFO Chris Clark is scheduled to present at the Deutsche Bank 40th Annual Health Care Conference on Wednesday, May 6, 2015, at 12:50 pm...

Read More

Neovasc Announces Results for the Fourth Quarter and Full Year Ended 2014

NASDAQ: NVCNTSX: NVC VANCOUVER, March 30, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced financial results for the fourth quarter and full year ended December 31, 2014.  All results are reported in Canadian dollars unless otherwise stated. 2014 Highlights First-in-human implantation...

Read More

Neovasc Launches Reducer in Select European Countries

NASDAQ: NVCNTSX: NVC VANCOUVER, March 19, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced the Neovasc Reducer™ has been introduced to select centers in Italy and will shortly be available for routine use at additional sites in Germany, the...

Read More

Neovasc to Participate at Upcoming Investor and Medical Conferences in February

NASDAQ: NVCNTSX: NVC VANCOUVER, Feb. 9, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that the Company will be participating at three upcoming conferences. 2015 Leerink Global Healthcare ConferenceWaldorf Astoria, New YorkWednesday, February 11, 2015 at 10:40 am ET Neovasc...

Read More

Neovasc closes offering of common shares

NASDAQ: NVCNTSX: NVC VANCOUVER, Feb. 3, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) is pleased to announce the closing of its previously announced underwritten public offering of 12,075,000 common shares of the Company at a price per share of US$7.19 (the "Offering")...

Read More

Neovasc increases size and prices offering of common shares

NASDAQ: NVCNTSX: NVC VANCOUVER, Jan. 29, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) is pleased to announce that due to market interest, it has increased the size of its previously announced underwritten public offering from 8,000,000 common shares to 10,500,000 common...

Read More